| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.009 |